Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 2
1999 2
2000 3
2001 1
2002 4
2003 1
2006 2
2007 1
2008 3
2010 4
2011 3
2012 6
2013 12
2014 16
2015 13
2016 12
2017 8
2018 16
2019 18
2020 14
2021 19
2022 16
2023 5
2024 6
2025 9
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
Japan Stroke Society Guideline 2021 for the Treatment of Stroke.
Miyamoto S, Ogasawara K, Kuroda S, Itabashi R, Toyoda K, Itoh Y, Iguchi Y, Shiokawa Y, Takagi Y, Ohtsuki T, Kinouchi H, Okada Y, Takahashi JC, Nakase H, Kakuda W; Committee for Stroke Guideline 2021, the Japan Stroke Society. Miyamoto S, et al. Among authors: takahashi jc. Int J Stroke. 2022 Oct;17(9):1039-1049. doi: 10.1177/17474930221090347. Epub 2022 Apr 20. Int J Stroke. 2022. PMID: 35443847 Free PMC article.
2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society.
Fujimura M, Tominaga T, Kuroda S, Takahashi JC, Endo H, Ogasawara K, Miyamoto S; Research Committee on Moyamoya Disease (Spontaneous Occlusion of Circle of Willis) of the Ministry of Health, Labor Welfare, Japan; Guideline Committee 2021 of the Japan Stroke Society. Fujimura M, et al. Among authors: takahashi jc. Neurol Med Chir (Tokyo). 2022 Apr 15;62(4):165-170. doi: 10.2176/jns-nmc.2021-0382. Epub 2022 Feb 22. Neurol Med Chir (Tokyo). 2022. PMID: 35197402 Free PMC article. No abstract available.
[Severity Classification of Moyamoya Disease].
Takahashi JC. Takahashi JC. No Shinkei Geka. 2025 May;53(3):463-466. doi: 10.11477/mf.030126030530030463. No Shinkei Geka. 2025. PMID: 40438008 Review. Japanese.
Disease progression, transient ischemic attack, and de novo parenchymal lesions in asymptomatic moyamoya disease: results of a 5-year interim analysis of the AMORE study.
Kuroda S, Yamamoto S, Funaki T, Fujimura M, Kataoka H, Hishikawa T, Takahashi JC, Endo H, Nariai T, Osato T, Saito N, Sato N, Hori E, Kashiwazaki D, Ito YM, Miyamoto S. Kuroda S, et al. Among authors: takahashi jc. J Neurosurg. 2024 Oct 18;142(3):658-666. doi: 10.3171/2024.6.JNS24736. Print 2025 Mar 1. J Neurosurg. 2024. PMID: 40367646
Moyamoya disease: recent progress and outlook.
Takahashi JC, Miyamoto S. Takahashi JC, et al. Neurol Med Chir (Tokyo). 2010;50(9):824-32. doi: 10.2176/nmc.50.824. Neurol Med Chir (Tokyo). 2010. PMID: 20885116 Free article. Review.
Moyamoya Disease Susceptibility Variant RNF213 p.R4810K Increases the Risk of Ischemic Stroke Attributable to Large-Artery Atherosclerosis.
Okazaki S, Morimoto T, Kamatani Y, Kamimura T, Kobayashi H, Harada K, Tomita T, Higashiyama A, Takahashi JC, Nakagawara J, Koga M, Toyoda K, Washida K, Saito S, Takahashi A, Hirata M, Matsuda K, Mochizuki H, Chong M, Paré G, O'Donnell M, Ago T, Hata J, Ninomiya T, Dichgans M, Debette S, Kubo M, Koizumi A, Ihara M. Okazaki S, et al. Among authors: takahashi jc. Circulation. 2019 Jan 8;139(2):295-298. doi: 10.1161/CIRCULATIONAHA.118.038439. Circulation. 2019. PMID: 30615506 No abstract available.
162 results